Skip to content

Case Study 投資案例:Great Bay Bio 大灣生物

  • by
Case Study 投資案例:Great Bay Bio 大灣生物

Video by Invest Hong Kong via YouTube
Case Study 投資案例:Great Bay Bio 大灣生物

Synergy at the Crossroads: Fusing Bioprocessing and AI for Innovative Solutions
結合生物製程與人工智能 開發創新解決方案

Headquartered in Hong Kong, Great Bay Bio (GBB) is an innovative biotechnology company that aims to enhance bioprocessing efficiency using artificial intelligence (AI) and cutting-edge technologies. Its mission is to elevate drug development efficiency and success rates, while also propelling progress in various bioprocessing sectors including synthetic biology, in vitro diagnostics (IVD), and cell and gene therapy (CGT). Recently, GBB has introduced multiple proprietary AI platforms for cell line development and cell culture media development technology services. As a trailblazer in the field, the company has secured 26 patents for its AI-powered bioprocessing solutions and has forged strategic collaborations with over 20 prominent companies at home and abroad.

Interested in setting up and expanding your business to HK?
Like our videos and subscribe to our YouTube Channel for latest updates

Visit us at:
InvestHK on LinkedIn:
InvestHK on Twitter:
InvestHK on WeChat: @InvestHK_HK
InvestHK on Weibo:

Go to Source